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Dendritic cells (DC) are well-known modulators of immunity. This heterogeneous popula-
tion is composed of defined subsets that exhibit functional specialization and are critical 
in initiating responses to pathogens. As such, many infectious agents employ strategies 
to disrupt DC functioning in attempts to evade the immune system. In some instances, 
this manifests as an outright loss of these cells. Previous work has suggested that, in the 
absence of an efficient natural killer (NK) cell response, murine cytomegalovirus (MCMV) 
induces large amounts of interferon (IFN)-I. This heightened IFN-I response is thought to 
contribute to conventional DC (cDC) loss and delayed development of T cell immunity. 
However, the precise role of IFN-I in such cDC loss remains unclear. We investigated the 
effects of licensed NK cells and IFN-I signaling on splenic cDC subsets during MCMV 
infection and found that a licensed NK cell response partially protects cDC numbers, 
but does not prevent increases in serum IFN-I. This suggested that high residual IFN-I 
could contribute to cDC loss. Therefore, we used multiple strategies to modulate IFN-I 
signaling during MCMV infection including plasmacytoid DC depletion, IFN-I receptor 
(IFNAR) blockade, and genetic ablation of IFNAR expression. Interestingly, restriction of 
IFN-I signals did not substantially preserve either CD8+ or CD4+ DC total numbers, but 
resulted in significant retention and/or accumulation of the splenic CD8− CD4− [double 
negative (DN)] subset. However, the DN DC effect manifested in a DC-extrinsic manner 
since IFNAR-deficient cells were not preferentially retained over their IFNAR wild-type 
counterparts in a mixed-chimera setting. Our results show that IFN-I signaling is not 
responsible for overt cDC toxicity in the setting of acute MCMV infection and emphasize 
that additional mechanisms contribute to DC loss and require exploration.
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inTrODUcTiOn
Due to their key involvement in pathogen detection, innate responses, and adaptive immunity, 
dendritic cells (DC) are prime targets for suppression by viral infections (1, 2). Although it is well 
established that the type I interferon (IFN)-I family plays important roles in the initial control of 
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many viral infections (3, 4), previous mouse studies have also 
suggested a causal role for IFN-I in splenic DC loss during infec-
tion or toll-like receptor stimulation (5–11). However, the exact 
contribution of IFN-I to DC loss is still unclear. It is thought that 
collapse of the DC compartment in such contexts can contribute 
to infection-induced immunosuppression at later time points. 
Previous work has shown that inefficient early control of murine 
cytomegalovirus (MCMV) leads to loss of DC numbers and can 
delay virus-specific CD8 T cell priming and memory precursor 
formation (5, 12, 13). If the process underlying DC loss is IFN 
dependent, a similar mechanism may help explain aspects of 
immunosuppression observed in human conditions marked by 
heightened inflammation, like HIV and sepsis (14–18).
Additional work has shown that natural killer (NK) cells can 
limit inflammation and protect DC—at least in the setting of 
MCMV infection (5, 8, 9). NK cell-dependent protection of DC 
in this setting is presumed to stem from their ability to limit viral 
spread and replication, thereby restricting the source material 
for plasmacytoid DC (pDC) stimulation and downstream IFN-I 
production (5, 10). Notably, many of the previous studies exam-
ining DC numbers in the context of MCMV control have been 
performed in mice with Ly49H+ NK  cells. Ly49H specifically 
binds MCMV-encoded m157 protein on the surface of infected 
cells, enabling NK cells to rapidly eliminate virally infected targets 
(19–23). However, NK  cell-mediated control also results from 
additional receptor–ligand interactions. For example, NK  cells 
that express the Ly49G2 inhibitory receptor (G2) can enhance 
MCMV resistance in mice that express the MHC class I molecule 
Dk (12, 13, 24–26). Dk is a cognate ligand of Ly49G2 and prompts 
G2+ NK cells to undergo an education process. These educated, or 
licensed, NK cells acquire the capability to detect alterations in Dk 
expression and orchestrate a more potent anti-MCMV immune 
response (12, 13, 24–26). The exact mechanism underlying this 
enhanced resistance is still under investigation, but the licensed, 
G2+ NK cell population is critical to the effect. Previous observa-
tions have indicated that this manifestation of MCMV control 
does not preserve DC to the same extent as a Ly49H-dependent 
response, but the role of IFN-I in the sustained DC loss is still 
unknown (12).
It is also unclear to what extent IFN-I affects individual 
subpopulations of DC during in  vivo MCMV infection. It is 
now known that the mouse spleen contains at least four distinct 
groups of DC, composed of pDC and three subsets of resident 
conventional DC (cDC). These distinct DC populations are dis-
tinguished by both their expression of surface molecules and their 
functional specializations. The pDC subtype is characterized by 
lower expression of CD11c and MHC II (compared to cDC), high 
expression of B220 and mouse pDC antigen (mPDCA), the capa-
bility to quickly produce large amounts of IFN-I, and a reduced 
ability to efficiently prime T  cell responses (27, 28). The bulk 
cDC population is broadly classified as CD11c-hi/MHC II+, and 
in the spleen and other lymphoid tissues, resident cDC subsets 
can be generally defined by their expression of CD8, CD11b, and 
CD4. The CD8+ DC subset (CD11b− CD8+ CD4−) is specialized 
for the uptake of dead cells and cross-presentation of extracel-
lular material to CD8+ T cells. These cells are critical for efficient 
CD8+ T cell priming in response to certain viral infections and 
immunogenic tumors (29). CD4+ DC (CD11b+ CD8− CD4+) are 
more efficient in vivo stimulators of CD4+ T cell responses, and 
their intestinal equivalents are required for a robust immune 
response to attaching and effacing bacteria (30, 31). Little is 
known about the functional specialization of double-negative 
(DN) DC (CD11b+ CD8− CD4−), but recent data indicate that 
these cells are superior cytokine producers compared to their 
CD4+ counterparts (30). Much progress has been made in iden-
tifying the transcription factors and developmental requirements 
for individual DC subsets (28), but our understanding of their 
regulation during infection and inflammation is still far from 
complete. Since IFN-I is known to cause pDC loss (32) and there 
is evidence indicating that IFN-I plays a role in cDC attrition 
(5, 6, 11), a deeper investigation into the requirement for this 
cytokine family in the context of cDC loss is warranted.
All members of the IFN-I cytokine family signal through 
a common IFN-I receptor (IFNAR). Therefore, the con-
tribution of IFN-I signaling to a specific phenotype can be 
efficiently investigated by disrupting the association between 
IFN-I and IFNAR (33–38). As a natural mouse pathogen 
known to induce high levels of IFN-I and to drive splenic 
DC loss (5, 8), MCMV infection represents an ideal setting to 
assess the impacts of IFN-I signaling on DC subset loss. Here, 
we investigated the effects of MCMV, NK  cell control, and 
IFN-I signaling on cDC numbers during acute MCMV infec-
tion. We found that, although cDC were partially protected 
in mice with G2+ NK-dependent resistance, IFN-I levels 
increased substantially in all mice during infection. Further 
investigation into the precise role of IFN-I revealed that CD8+ 
and CD4+ DC subset loss can occur independently of IFN-I 
stimulation, but DN DC numbers benefit from the removal 
of IFN-I signals.
MaTerials anD MeThODs
Mice
C57L-derived MHC I Dk-disparate congenic mouse strains 
R7 and R2 (referred to as Dk and non-Dk, respectively) were 
previously generated and described (39). C57Bl/6 (B6)-derived 
IFNAR-KO mice (B6.129S2-Ifnar1tm1Agt/Mmjax) were obtained 
from the Mutant Mouse Resource & Research Centers. CD45.1 
(45.1) mice (B6.SJL-Ptprca Pepcb/BoyJ) were purchased from 
The Jackson Laboratory. Congenic B6 mice harboring the 
natural killer gene complex (NKC) haplotype from C57L mice 
(B6.NKCc57l; referred to here as NKCl) were generated and 
described previously (13). NKCl mice lack the Ly49h gene and, 
consequently, Ly49H+ NK cells (13). NKCl and IFNAR-KO mice 
were crossed to generate B6.Cg-Nkcc57l-129S2-Ifnar1tm1Agt (aka 
B6.NKCl IFNAR-KO). IFNAR wild-type (IFNAR-WT) and 
IFNAR-heterozygous (IFNAR-het) littermates from the crosses 
were included as comparators in experiments. This study was car-
ried out in accordance with the recommendations of the Animal 
Welfare Act and the recommendations in the Guide for the Care 
and Use of Laboratory Animals of the National Institutes of 
Health. The protocol was approved by the University of Virginia 
Animal Care and Use Committee.
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McMV infection and immune cell 
Depletion
Mice were i.p. injected with salivary gland passaged MCMV 
(Smith strain ATCC VR1399; 5 ×  104 PFU/mouse, or as indi-
cated). For depletion of pDC, mice were i.p. injected twice with 
250  μg monoclonal antibody (mAb) 927 (kindly provided by 
Marco Colonna) (40) 48 and 24 h prior to infection. For depletion 
of G2+ NK cells, mice were i.p. injected with 200 μg mAb 4D11 
(hybridoma kindly provided by Wayne Yokoyama) 48 h prior to 
infection. For blocking IFNAR, mice were i.p. injected with 1 mg 
mAb MAR1-5A3 (Leinco Technologies, Inc.) before infection 
and 500 μg every 24 h thereafter. For blocking Ly49H receptors, 
mice were i.p. injected with 200 μg mAb 3D10 (hybridoma also 
provided by Wayne Yokoyama) 24 h prior to infection.
splenic Dc harvest and Flow cytometry
Disrupted spleen tissues were digested with collagenase D 
(Roche) and processed with Falcon cell strainers essentially as 
described (41). Splenocytes were Fc blocked with mAb 2.4G2 
and stained with mAb purchased from eBiosciences, BioLegend, 
BD Pharmingen, and Miltenyi including 2G9 (MHC II), 53-6.7 
(CD8), MAR1-5A3 (IFNAR1), 145-2C11 (CD3), 6D5 (CD19), 
P84 (SIRPα), N418 (CD11c), HL3 (CD11c), 129c1 (mPDCA), 
M1/70 (CD11b), GK1.5 (CD4), RA3-6B2 (B220), 53-2.1 (Thy1.2), 
A20 (CD45.1), 104 (CD45.2), and 30-F11 (pan-CD45). LIVE/
DEAD® Viability Dye (Invitrogen) was used for dead cell exclu-
sion. Samples were run on a BD Canto II with Diva acquisition 
software and analyzed using FlowJo v10. Detailed gating strate-
gies are illustrated in supplemental material (Figures S1 and S2 
in Supplementary Material). Cell numbers were quantified via a 
series of calculations. Whole spleens and spleen fractions pro-
cessed for flow cytometry were weighed to determine their mass. 
The number of splenocytes per flow sample was determined using 
a hemocytometer, and this was converted to splenocytes/g tissue. 
FlowJo data were then used to determine the number of DC/total 
splenocytes. This allowed us to calculate the number of DC/g tis-
sue and then adjust for the total mass of the whole spleen.
A population of CD11c+ MHC II+ cells from infected mice was 
observed that displayed significantly increased CD11b expression 
and higher side scatter values. Thus, these cells were regarded as 
inflammatory monocytes/inflammatory DC and were excluded 
from analyses, as indicated in Figures S1 and S2 in Supplementary 
Material.
iFnα elisa
Blood was collected via tail bleed or postmortem cardiac punc-
ture. Serum was isolated by allowing blood to clot followed by 
centrifugation. IFNα quantitation was performed with VeriKine 
Mouse IFN Alpha ELISA kits (PBL) according to the manufac-
turer’s instructions.
Bone Marrow (BM) chimeric Mice
Bone marrow transplantations were performed essentially as 
described (25). Briefly, B6 mice were irradiated twice with 5.5 Gy 
(11 Gy total) over a span of 3 h. Twenty-four hour later, i.v. injec-
tion of ~4.5 ×  106 total donor BM  cells was performed, either 
IFNAR-KO (45.2), -WT (45.1), or a 1:1 mix. Recipient mice 
were maintained on sulfate drinking water for 3 weeks following 
irradiation. Peripheral blood analysis was performed at 4 weeks 
to assess BM chimerism. After 8  weeks, recipients were 3D10 
treated to block the Ly49H receptor and i.p. infected 24 h later. 
Splenocytes were analyzed 3 days postinfection (d.p.i.). Due to 
limited flow cytometer channels in the BM chimera experiments, 
we defined CD8+ DC by low SIRPα and CD4 expression (28) to 
evaluate cDC subsets side by side. However, results were further 
confirmed by a separate analysis for CD8+ DC specifically (Figure 
S3 in Supplementary Material).
Quantification of McMV genomes
Virus levels were measured by determining the ratio of viral 
genomes to β-actin in DNA isolated from tissue samples. DNA 
was isolated using the Gentra Puregene tissue kit according to 
the manufacturer’s instructions. Isolated DNA was analyzed by 
quantitative real-time PCR as described previously (42).
statistical analysis
Since our samples sizes are not large enough to verify normality 
of the data, significance was determined with the non-parametric 
Mann–Whitney (two groups) or Kruskal–Wallis (more than two 
groups) tests using GraphPad Prism and XLSTAT software. If the 
Kruskal–Wallis test rejected the null hypothesis, a Conover–Iman 
post hoc test was run for multiple comparisons using XLSTAT. 
Significance is represented as follows: *p <  0.05, **p  <  0.01, 
***p < 0.001, and ****p < 0.0001. Error bars denote SD. Dots on 
graphs represent individual animals.
resUlTs
licensed nK cell Protection of cDc during 
acute McMV infection
Previous work has shown that Ly49H+ NK  cells can preserve 
splenic cDC numbers during MCMV infection (5, 8, 9). 
However, the role of self-MHC I licensed NK cells in cDC pro-
tection has been minimally explored. We therefore examined 
the effect of Dk-licensed G2+ NK cells on cDC populations dur-
ing MCMV infection. Similar to prior work (12), we observed 
that total splenic cDC numbers declined by 3 d.p.i. in all mice 
(Figure  1A). The majority of loss occurred in the CD8+ and 
CD4+ DC subsets, whereas DN DC were largely unaffected 
(Figure 1B). However, overall cDC loss was less prominent in 
Dk mice with licensed G2+ NK cells, suggesting that the virus 
control mediated by these cells can enhance cDC retention. 
Both CD8+ and CD4+ DC numbers were higher in Dk mice com-
pared to non-Dk, but DN DC numbers were equivalent across 
all mice (Figure  1B). These results suggest that distinct cDC 
subsets are differentially sensitive to MCMV infection, and, as 
a result, licensed G2+ NK  cell control differentially enhances 
subset numbers.
We further examined the importance of licensed NK  cell-
mediated control by specifically depleting G2+ NK  cells prior 
to MCMV infection. Without Ly49G2+ NK cells, cDC loss was 
exacerbated in Dk mice compared to isotype-treated control 
FigUre 1 | licensed natural killer (nK) cells partially protect conventional dendritic cell (cDc) during acute murine cytomegalovirus (McMV) 
infection. (a,B) Dk and non-Dk mice were mock (PBS) or MCMV infected for 3 days. Splenocytes were stained with fluorescent mAbs (mAb) and assessed for 
cDCs by flow cytometry. (a) Concatenated flow plots showing gated dendritic cells (DC) populations. DC numbers are quantified in the graph. (B) As in (a) except 
cDC subsets are analyzed. (c,D) Dk mice were treated with rIgG or mAb 4D11 to deplete Ly49G2+ NK cells (α-G2) 48 h prior to MCMV infection. Mice were mock 
(PBS) or MCMV infected for 3 days, and splenocytes were assessed for cDC. (c) Concatenated flow plots showing gated DC populations. DC numbers are 
quantified in the graph. (D) As in (c) except cDC subsets are analyzed. Numbers on flow plots denote frequency of parent population. Graphs show results for 
individual mice (dots) and group means (bars). Results are representative of at least two experiments.
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mice; this was similar to the results obtained for non-Dk versus 
Dk mice (Figure 1C compared to Figure 1A). Individual cDC 
subset loss also mirrored the patterns from Dk and non-Dk mice. 
Reductions in cDC were observed in all infected mice, with 
CD8+ and CD4+ DCs constituting the entirety of cDC loss, while 
DN DC numbers remained unchanged (Figure 1D compared to 
Figure 1B). Loss of CD8+ and CD4+ DC was aggravated by the 
absence of G2+ NK cells, further demonstrating that an effective 
licensed NK cell response to MCMV can promote cDC retention. 
We considered the possibility that Ly49G2 depletion itself could 
have resulted in cDC loss, but no differences in DC numbers 
were detected following G2 depletion in the absence of infection 
(Figure S4A in Supplementary Material). We are also confident 
that protection is a Ly49G2-specific effect in these mice since 
all non-G2 NK cell subsets were preserved in G2-depleted mice 
(Figure S4B in Supplementary Material). Thus, CD8+ and CD4+ 
DCs are specifically sensitive to MCMV-induced loss, which 
is amplified in mice without licensed NK  cell-mediated virus 
control.
pDc Depletion reduces systemic iFn-i 
and increases Dn Dc numbers, but Does 
not restore cD8+ or cD4+ Dc
Since licensed NK cell-mediated virus control did not fully pro-
tect cDC populations, we further investigated the basis of cDC 
loss. It has been suggested that excessive IFN-I production from 
pDC could lead to cDC loss during infection (5, 10, 11). In this 
context, our data implied that licensed NK  cells might reduce 
IFN-I levels enough to blunt cDC loss, but not enough to allow 
FigUre 2 | Plasmacytoid dendritic cell (pDc) depletion reduces systemic interferon (iFn)-i and increases double-negative dendritic cell (Dc) 
numbers, but does not restore cD8+ or cD4+ Dc. (a) Dk and non-Dk mice were infected with 2 × 104 PFU murine cytomegalovirus (MCMV), and serum IFNα 
levels were assessed 36 h post infection (p.i.) by ELISA. Results are pooled from two separate experiments with three to four mice per group each. (B–e) Non-Dk 
mice received either isotype control (rIgG) or monoclonal antibody (mAb) 927 (α-pDC) 48 and 24 h prior to infection to deplete pDC. Mice were mock (PBS) or 
MCMV infected (2 × 104 PFU) for 4 days. Splenocytes were stained with fluorescent mAbs and assessed for cDCs by flow cytometry. (B) Concatenated flow plots 
show pDC populations at 4 days p.i. (c) Graph shows serum IFNα levels at 36 h p.i. as assessed by ELISA (data pooled from two experiments). (D) Concatenated 
flow plots show gated DC populations. DC numbers are quantified in the graph. (e) As in (D) except cDC subsets are analyzed. Numbers on flow plots denote 
frequency of parent population. Graphs show results for individual mice (dots) and group means (bars). Results are representative of at least two experiments.
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complete retention. Indeed, both Dk and non-Dk mice exhibited 
large increases in serum IFNα during early infection, but Dk mice 
produced lower amounts overall than non-Dk mice (Figure 2A). 
These data fit the hypothesis that high IFN-I could account for the 
residual cDC loss observed in Dk mice.
To further examine the role of IFN-I, we specifically depleted 
pDC before infection. We examined susceptible (non-Dk) mice 
since the mechanism of cDC loss should be similar in Dk and non-
Dk settings if IFN-I toxicity is responsible. Furthermore, cDC 
protection should be readily detectable in a susceptible setting 
since loss is profound in these mice. As expected, the α-pDC mAb 
treatment effectively reduced the pDC population and serum 
IFNα levels (Figures 2B,C). The pDC depletion also resulted in 
increased numbers of cDC, but the majority of the effect was due 
to an expanded DN DC compartment (Figures 2D,E). Neither 
CD8+ nor CD4+ DC numbers were fully restored by the removal 
of pDC. These results suggest that pDC and pDC-derived IFN-I 
are unlikely to be responsible for the loss of CD8+ and CD4+ DC, 
although they may restrict DN DC during infection.
iFnar Blockade increases Dn Dc 
numbers but Does not Protect cD8+ and 
cD4+ Dc
Although pDC are responsible for the bulk of IFN-I released prior 
to 48 h p.i., additional cell types also produce IFN-I during the 
course of MCMV infection (e.g., cDC, stromal cells, macrophages) 
(43). Hence, these could contribute to cDC loss in the absence 
of pDC if cDC loss is truly dependent on IFN-I signaling. We 
therefore broadly impaired IFN-I responses by blocking IFNAR 
signaling in non-Dk mice. Receptor occupancy was assessed by 
staining DC with fluorophore-conjugated α-IFNAR. As expected, 
IFNAR-blocked DC were much less effectively stained than DC 
from isotype-treated mice (Figure  3A). Inhibition of IFNAR 
signaling was verified by measuring mPDCA upregulation 
on DC and B  cells, since surface mPDCA expression is highly 
responsive to IFN-I stimulation (44). Cells from IFNAR-blocked 
mice expressed much lower levels of mPDCA in comparison to 
isotype-treated controls (Figure  3B). Expression of the activa-
tion markers CD69 and CD86 was also much lower on T cells, 
FigUre 3 | interferon-i receptor (iFnar) blockade increases double-negative dendritic cells (Dc) numbers but does not protect cD8+ and cD4+ Dc. 
Non-Dk mice were treated with isotype control (mIgG) or monoclonal antibody (mAb) MAR1-5A3 (α-IFNAR) prior to and throughout murine cytomegalovirus infection 
to block IFNAR signaling. Mice were infected for 3 days, and splenocytes were stained with fluorescent mAb and assessed by flow cytometry. (a) Concatenated 
histograms show ex vivo staining of DC with fluorescent α-IFNAR. Median fluorescent intensity of IFNAR staining is quantified in the graph. FMO, fluorescence minus 
one negative control. (B) As in (a) but data for surface mPDCA staining is shown for DC (above) and B cells (below). (c) Concatenated flow plots show gated DC 
populations. DC numbers are quantified in the graph. (D) As in (c) except conventional DC subsets are analyzed. Numbers on flow plots denote frequency of parent 
population. Graphs show results for individual mice (dots) and group means (bars). Results are representative of at least two experiments.
6
Nash et al. IFN-I-Independent DC Subset Loss
Frontiers in Immunology | www.frontiersin.org March 2017 | Volume 8 | Article 251
B  cells, and/or DC from IFNAR-blocked mice (Figure S5 in 
Supplementary Material).
Similar to pDC depletion, we observed a greater number of 
cDC in IFNAR-blocked mice (Figure 3C). However, this again 
stemmed largely from an increase in DN DC (Figure  3D). 
Although higher CD8+ DC numbers were also detected in 
IFNAR-blocked spleens, their overall retention was negligible 
when compared to numbers observed in mock-infected mice 
(Figure 3D compared to PBS in Figures 1 and 2). CD4+ DC num-
bers were unaffected by IFNAR blockade and declined equally in 
all mice during MCMV infection (Figure 3D compared to PBS 
in Figures 1 and 2). In aggregate, these results indicated that the 
loss of CD8+ and CD4+ DCs during MCMV infection is largely 
IFN-I independent, but IFN-I signaling specifically limits DN DC 
numbers.
McMV-induced loss of cD8+ and cD4+ 
Dc Persists in the absence of iFnar 
signaling
To exclude the possibility of low-level IFN-I signaling despite 
IFNAR blockade, we repeated the experiments in IFNAR-
deficient (IFNAR-KO) C57BL/6 (B6) mice. Although we had 
thus far examined cDC in C57L-derived mice, C57L and B6 
mice are genealogically related (45), but encode distinct Ly49 
receptors in their respective NKC haplotypes (46–49). Notably, 
the B6 NKC encodes Ly49H, which mediates MCMV resistance 
(19–23), whereas C57L mice lack Ly49H expression. We there-
fore mitigated this NKC difference in our experiments by Ly49H 
blockade or congenic replacement of the B6 NKC with the C57L 
NKC (NKCl mice; see Materials and Methods). When cDC loss 
was assessed in the B6 background, isotype-treated, Ly49H-
sufficient mice retained total cDC, CD8+ DC, and DN DC 
numbers (Figure 4A). Unexpectedly, although, they exhibited a 
strong trend toward loss of CD4+ DC, emphasizing the sensitiv-
ity of this population to infection-induced loss (Figure 4A). The 
reduced number of CD4+ DC was apparently compensated for 
by a slight increase in DN DC—thereby maintaining total cDC 
numbers. B6 mice lacking Ly49H-mediated resistance (α-Ly49H 
and NKCl) displayed pronounced overall loss of cDC numbers 
(Figure  4A). This included significant decreases in CD8+ 
and CD4+ DC but, unlike C57L-derived mice, also included 
significant loss of DN DC numbers (Figure  4A). These data 
showed that, when B6 mice lack Ly49H-mediated resistance, 
MCMV-induced cDC loss is at least similar to that observed 
on the C57L background and, potentially, more profound given 
the DN DC data.
FigUre 4 | Murine cytomegalovirus (McMV)-induced loss of cD8+ and cD4+ dendritic cell (Dc) persists in the absence of interferon-i receptor 
(iFnar) signaling. B6 and B6-derived mice were mock (PBS) or MCMV infected for 3 days. Infected mice were either B6 WT controls (mIgG), Ly49H-blocked B6 
WT (α-Ly49H), or Ly49H-deficient B6 congenic mice (NKCl). Splenocytes were stained with fluorescent monoclonal antibodies (mAb) and assessed for cDCs by flow 
cytometry. (a) Concatenated flow plots show gated DCs (above) and cDC subsets (below). Cell numbers for each population are quantified in the graphs.  
(B) Ly49H-deficient mice were bred with IFNAR-KO B6 mice to generate B6.NKCl with WT (IFNAR-WT), heterozygous (IFNAR-Het), or null (IFNAR-KO) IFNAR 
expression. Mice were mock (PBS) or MCMV infected for 3 days, and splenocytes were stained with fluorescent mAb for analysis. Concatenated flow plots show 
DC (above) and cDC subsets (below) for each group. Cell numbers for each population are quantified in the graphs. Numbers on flow plots denote frequency of 
parent population. Graphs show results for individual mice (dots) and group means (bars). Results are representative of at least two experiments.
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We crossed B6.IFNAR-KO and NKCl mice to gener-
ate B6.NKCl IFNAR-KO animals, which lack both Ly49H 
and IFNAR expressions (IFNAR-KO). This also yielded 
IFNAR-WT and IFNAR-Het littermates (Figure S6 in 
Supplementary Material), which were used as comparators. 
Upon challenge with MCMV, none of the mice displayed 
enhanced cDC retention, regardless of IFNAR expression 
status (Figure  4B). This contrasts somewhat with results 
from C57L mice, which maintained cDC numbers following 
IFNAR blockade due to an increase in DN DC. The lack of 
cDC retention was accompanied by a corresponding failure 
to increase DN DC numbers (Figure  4B). It is unclear why 
DN DC behaved differently in these IFNAR-KO mice, but 
such results could indicate that these cells are programmed 
differently when IFNAR signaling is absent throughout 
development rather than transiently blocked on mature 
cells. Alternatively, additional genetic modifiers could have 
altered DN DC behavior in this setting. Nonetheless, CD8+ 
FigUre 5 | generation and characterization of bone marrow (BM) chimeras. (a) Schematic for generation and analysis of BM chimeric mice. Irradiated B6 
recipients were reconstituted with interferon-I receptor (IFNAR)-KO BM (45.2), IFNAR wild-type (IFNAR-WT) BM (45.1), or a 1:1 mix of both. Mixed chimerism was 
assessed in peripheral blood at 4 week postreconstitution. At 8 week postreconstitution, mice were mock (PBS) or murine cytomegalovirus (MCMV) infected for 
3 days. A subgroup of the mixed chimeras were used as the PBS controls. Splenocytes were stained with fluorescent monoclonal antibodies for analysis by flow 
cytometry. (B) Concatenated flow plots show staining of CD45.2 and CD45.1 on B cells from mixed BM chimeras. Analysis was performed on peripheral blood at 
4 week postreconstitution (left) and on spleen cells at the conclusion of the experiment (right). Concatenated histograms show IFNAR expression profiles of the 
CD45.1 versus CD45.2 marked cells (far right). (c) Surface mouse pDC antigen (mPDCA) expression was assessed on splenic B cells 3 days post infection. 
Concatenated histograms show surface mPDCA expression, and graphs show quantified MFI values. Top panels depict B cells from IFNAR-WT chimeras alongside 
B cells from IFNAR-KO chimeras. Middle panels depict CD45.1 and CD45.2 cells from infected mixed chimeras. Bottom panels depict CD45.1 and CD45.2 cells 
from PBS-treated mixed chimeras. All graphs show data for individual mice (dots) and group means (bars). Results are representative of at least two experiments.
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and CD4+ DC loss was also comparable across all IFNAR 
genotypes (Figure  4B). The results demonstrated that cDC 
loss progressed similarly in the presence or absence of IFNAR 
signaling.
cell-intrinsic iFnar Deficiency Does not 
Promote cDc subset retention
Global blockade and genetic ablation of IFN-I signaling can 
broadly alter cytokine profiles, immune cell responses, and 
overall host resistance to viral infection—all of which could 
influence DC numbers (3, 43, 50, 51). Thus, we considered 
that such reduced virus control could induce additional 
mechanisms of DC loss and interfere with our ability to 
detect IFN-I-dependent toxicity. To verify the degree of 
IFN-I-intrinsic toxicity in cDC populations, we generated a 
panel of BM chimeras with varying combinations of IFNAR 
expression. B6 mice were used as BM transplant recipients to 
preserve WT IFNAR signaling in stromal cells. These cells 
are primary targets of MCMV and IFN-I signaling in this 
compartment is important for limiting initial virus spread 
(4, 52, 53). B6 hosts were reconstituted with IFNAR-WT 
BM (CD45.1+), IFNAR-KO BM (CD45.2+), or a 1:1 mix to 
generate hematopoietic cell compartments with full, null, or 
half IFNAR-signaling capability (Figure  5A). As expected, 
IFNAR-KO B  cells from IFNAR-KO and mixed chimeras 
lacked IFNAR expression (Figure 5B) and failed to upregu-
late mPDCA in response to MCMV (Figure  5C). Thus, 
IFNAR-KO cells remained IFN-I insensitive in all chimeric 
settings.
As expected, manipulation of IFN-I signaling resulted 
in increased virus levels (Figures  6A,B). Therefore, we also 
assessed MCMV genome levels in the spleens of the BM chi-
meras. At 3 d.p.i., the spleens of all chimeric mice exhibited 
similar viral burdens (Figure 6C). Hence, a difference in virus 
levels was not a complicating factor in the analysis of chimeric 
mice. We first analyzed total splenic cDC without distinguishing 
between CD45.1 and CD45.2 cells (bulk cDC). The cDC were 
substantially reduced in all infected chimeras when compared 
to uninfected controls (Figure  7A). However, despite the fact 
FigUre 6 | Bone marrow (BM) chimeric mice control murine 
cytomegalovirus (McMV) equally. Viral genomes in infected spleen tissue 
was measured using real-time PCR and is shown as a ratio normalized by 
endogenous β-actin. (a) Virus levels in the spleens of isotype-treated (mIgG) 
or interferon-I receptor (IFNAR)-blocked (α-IFNAR) mice. (B) Virus levels in the 
spleens of IFNAR-WT (WT) or IFNAR-KO (KO) B6.NKCl mice. (c) Virus levels 
in the spleens of infected IFNAR-WT, IFNAR-KO, and mixed BM chimeras.
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that cDC decreased in all infected mice, KO chimeras exhibited 
a significant retention over both mixed and WT settings. This, 
again, was solely due to retention of the DN DC subset since 
there was no appreciable increase in the number of CD8+ or 
CD4+ DC in KO chimeras (Figure  7A). Thus, hematopoietic 
IFNAR deficiency does not protect CD8+ and CD4+ DC, though 
it is sufficient to maintain DN DC numbers at levels equal to 
those seen in uninfected mice.
Direct comparison of CD45.1 and CD45.2 DC in mixed BM 
chimeras revealed that none of the subsets preferentially retained 
IFNAR-KO cells during infection (Figures  7B–D). However, 
IFNAR-KO DN DC trended toward higher numbers and did 
not differ significantly from either WT or KO populations in 
uninfected mice, which could indicate an intrinsic retention 
benefit. Overall, the data show that, during MCMV infection, DN 
DC numbers are the most responsive to IFN-I regulation, while 
profound CD8+ and CD4+ DC loss can occur independently of 
IFN-I.
DiscUssiOn
Despite their well-established protective role during the initial 
stages of viral infection, IFN-I can also manifest immune 
regulatory or suppressive effects, depending on the target cell 
and signaling context (3, 54). A reduction in DC has also been 
observed during human inflammatory conditions (e.g., HIV 
infection and sepsis) and may contribute to immunosuppression 
during chronic infection and illness (18, 55–58). Although high 
IFN-I responses are a hallmark of both HIV and sepsis (59–62), 
a direct causal relationship between IFN-I and DC loss has not 
been demonstrated. Previous work with murine models has cor-
related high IFN-I levels with DC loss, potentially via direct cDC 
toxicity (5, 6, 11, 63, 64). This correlation seemingly indicates that 
blocking early IFN-I responses could preserve DC numbers. This 
is an important consideration from a clinical standpoint, since 
the ability to regulate DC numbers is relevant to a wide variety 
of diseases. As such, the relationship between IFN-I and DC 
merits better understanding. The current work demonstrates that 
blocking IFN-I is not sufficient to protect or restore DC numbers 
and, furthermore, could result in an inability to efficiently control 
acute infections.
Previous work with lymphocytic choriomeningitis virus 
(LCMV) and poly I:C has correlated IFN-I with diminished DC 
populations. During LCMV infection, IFNAR-KO mice show 
improved retention of CD4+, CD8+, and DN DC with fewer 
DC that become annexin V+ during ex vivo culture (11). After 
poly I:C treatment, IFNAR-KO mice retain CD8+ and CD11b+ 
DC in greater numbers than their IFNAR-WT counterparts 
(6). Surprisingly, we did not observe the same outcomes in 
IFNAR-KO mice during MCMV infection. It is unclear why our 
results differ from these previous studies, but inherent differ-
ences between the responses to LCMV, poly I:C, and MCMV 
could be responsible.
While the current work shows a decoupling of IFN-I signaling 
and DC loss, we did not directly assess IFN-I’s potential to specifi-
cally drive cDC loss. However, additional work using exogenous 
IFN-I has provided insight into this issue. Naïve mice transiently 
enhance annexin V and TUNEL staining on CD8+ splenic DC fol-
lowing IFN-I treatment, but simultaneously increase the turnover 
rate of all splenic cDC (64). Interestingly, the authors specifically 
note that total DC numbers never diminished in these experi-
ments. Hence, the data are consistent with IFN-I-coordinated 
regulation of cDC turnover, rather than broad toxicity. On the 
other hand, IFN-I treatment of MCMV-infected Ly49H+ mice 
results in a decrease in both CD8+ and CD11b+ DC (5). However, 
the degree of enhanced DC loss is intermediate. These mice still 
retain greater numbers of DC than susceptible, Ly49H− mice 
during MCMV infection. The addition of IFN-I, therefore, does 
not recapitulate the entirety of cDC loss triggered by inefficient 
MCMV control. These studies not only provide valuable insight 
into DC regulation by IFN-I but also highlight the importance of 
IFN-I-independent elements.
Although MCMV is a potent inducer of cDC loss, NK cells 
clearly play a role in regulating DC numbers during infection. 
Ly49H+ NK cells are well known for their efficient anti-MCMV 
activity, and DC numbers are preserved during Ly49H+ 
responses (5, 8, 9). Lower IFN-I production in Ly49H+ mice 
has been proposed as an explanation for this DC preservation. 
In C57L mice, expression of Dk and the C57L allele of Ly49G2 
allows G2+ NK cells to control MCMV (12, 24, 25, 39). However, 
our results show that IFN-I is still substantially elevated in 
these resistant mice. Despite a robust IFN-I response, DC 
protection still occurs, which indicates that the protective 
effect of NK cells is more likely due to efficient virus control. 
Specific recognition of MCMV infection appears to be a key 
element of the G2+ NK cell effect. Thus, DC protection is not a 
universal function of licensed NK cells, but rather corresponds 
to effective NK  cell-mediated virus control. The mechanism 
underlying G2+ NK-mediated MCMV control is an important 
area of ongoing investigation and will provide further insight 
into the role of licensed NK cell responses in regulating cDC 
populations.
The ability of G2+ NK cells to preserve CD8+ and CD4+ DC 
despite heightened IFN-I, coupled with the inability to preserve 
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FigUre 7 | interferon-i receptor (iFnar) deficiency does not provide conventional dendritic cell (cDc) subsets with an inherent retention benefit.  
(a) Total splenocytes from mock- and murine cytomegalovirus (MCMV)-infected BM chimeras were analyzed without distinguishing between CD45.1 or CD45.2 
expression. Concatenated flow plots show analysis of dendritic cell (DC) (above) and cDC subsets (below). Cell numbers for each population are quantified in the 
graphs. (B–D) cDC subsets from the mixed chimeras in (a) were separated into IFNAR-KO (45.2) and -WT (45.1) populations and analyzed side by side. 
Concatenated flow plots show the separation and relative frequency of KO versus WT cells for each subset from mock- (PBS) and MCMV-infected mixed chimeras. 
Cell numbers for each population are quantified in the graphs. Numbers on flow plots denote frequency of parent population. All graphs show data for individual 
mice (dots) and group means (bars). Results are representative of at least two experiments.
these cells by removing IFN-I signals, indicates that IFN-I toxic-
ity is not a major driver of CD8/4 DC loss in our experiments. 
This opens the important issue of alternative explanations for 
diminished DC numbers. During MCMV infection of mixed 
BM chimeras, IFNAR-WT DC show increased expression in 
both proapoptotic and antiapoptotic genes that is not present in 
IFNAR-KO DC, but the frequency of apoptotic DC remains low 
despite an overall loss of DC numbers (65). As a result, inefficient 
replacement from precursors was proposed as a potential mecha-
nism. Prolonged IFN-I exposure can interfere with the ability 
of BM precursors to generate DC in  vivo (63), making this a 
reasonable alternative to DC toxicity and death. However, our 
data suggest that IFN-I effects on DC precursors are unlikely 
to explain DC loss. If IFN-I signals diminish or inhibit pre-DC, 
abrogating IFNAR signaling should restore cDC numbers. In 
contrast to this prediction, there was no preservation of CD8+ or 
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FigUre 8 | graphical summary showing major dendritic cell (Dc) regulation in c57l and B6 mice. (a) When compared to naïve mice, murine 
cytomegalovirus (MCMV)-infected C57L mice exhibit a decrease in CD8+ and CD4+ DC subsets, while double-negative (DN) DC numbers remain unchanged. 
Removal of interferon (IFN)-I signals does not restore CD8+ or CD4+ DC numbers, but does relieve an IFN-I-imposed limit on DN DC, resulting in increased numbers. 
Licensed Ly49G2+ NK-mediated MCMV control partially restores CD8+ and CD4+ DC. High levels of IFN-I, however, still specifically limits DN DC. (B) In the absence 
of Ly49H+ NK-mediated control, MCMV-infected B6 mice exhibit a decrease in CD8+, CD4+, and DN DC. Similar to the C57L setting, removal of IFN-I signals does 
not restore CD8+ or CD4+ DC, but alleviates the IFN-I-imposed restriction on DN DC. During Ly49H+ NK-mediated MCMV control, both virus levels and IFN-I are 
decreased compared to susceptible mice, resulting in preservation of all three conventional DC subsets.
CD4+ DC in our IFNAR blockade and IFNAR-KO experiments. 
This does not rule out potential IFN-I-independent effects on DC 
precursors, so inefficient development/differentiation may still 
play a role in DC loss. Additional explanations include cellular 
conversion or trafficking out of the spleen. We cannot rule out the 
possibility that CD8+ and CD4+ DC could alter expression of cell 
surface molecules, thereby taking on the appearance of another 
cell type, possibly even that of DN DC. Sophisticated cell tracking 
experiments will be needed to effectively explore these questions 
further.
Another important consideration is that of subset specific 
patterns of regulation. The current study demonstrates dif-
ferential retention within CD11b+ DC subsets during MCMV 
infection. CD4+ DC patterns more closely resemble CD8+ DC, 
rather than their DN counterparts. DN DC numbers were gener-
ally enhanced when IFN-I signaling was impaired, but CD4+ DC 
numbers were virtually unaffected by IFN-I. In addition, DN DC 
exhibited less severe loss under all conditions explored in our 
study. This phenomenon has also been noted in mice during 
LCMV infection and in sepsis models (11, 58, 66). The divergence 
of CD4+ and DN DC during MCMV infection is intriguing, 
particularly given the functional specializations of cDC subsets. 
Preferential retention or loss of specific subsets during infection 
could influence the priming and/or differentiation of adaptive 
immune cells, thereby influencing the development of protective 
immunity.
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